ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc (RXRX)

6.13
0.00
(0.00%)
마감 11 3월 5:00AM
0.00
0.00
(0.00%)
시간외 거래: -

행사 가격매수가매도가최근 가격중간 가격가격 변동가격 변동 %거래량미결제 약정최근 거래
2.002.606.104.654.350.000.00 %1011/03/2025
2.502.105.604.253.850.000.00 %1011/03/2025
3.001.504.403.762.950.000.00 %02-
3.501.004.600.002.800.000.00 %00-
4.000.603.600.002.100.000.00 %00-
4.500.502.952.201.7250.000.00 %00-
5.000.701.352.251.0250.000.00 %05-
5.500.650.750.720.70-0.13-15.29 %65811/03/2025
6.000.300.400.400.35-0.35-46.67 %1717311/03/2025
6.500.150.200.150.175-0.24-61.54 %60633311/03/2025
7.000.050.100.060.075-0.14-70.00 %1,0444,81311/03/2025
7.500.110.050.040.08-0.07-63.64 %12882511/03/2025
8.000.060.050.060.0550.000.00 %01,431-
8.500.090.050.030.07-0.06-66.67 %549611/03/2025
9.000.030.050.020.04-0.01-33.33 %2167811/03/2025
9.500.030.050.030.040.000.00 %01,598-
10.000.050.050.030.05-0.02-40.00 %136811/03/2025
10.500.030.050.030.040.000.00 %01,244-

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

행사 가격매수가매도가최근 가격중간 가격가격 변동가격 변동 %거래량미결제 약정최근 거래
2.000.000.050.000.000.000.00 %00-
2.500.000.050.000.000.000.00 %00-
3.000.050.050.050.050.000.00 %01-
3.500.000.100.000.000.000.00 %00-
4.000.000.250.000.000.000.00 %00-
4.500.080.050.080.0650.000.00 %01-
5.000.050.050.050.050.000.00 %31110/03/2025
5.500.050.150.150.100.0550.00 %1332111/03/2025
6.000.200.250.250.2250.14127.27 %96853911/03/2025
6.500.500.600.530.550.2376.67 %14640011/03/2025
7.000.901.000.900.950.2538.46 %2285811/03/2025
7.501.351.501.381.4250.3533.98 %41,10111/03/2025
8.001.852.001.951.9250.6044.44 %26111/03/2025
8.502.002.951.972.4750.000.00 %054-
9.002.303.202.522.750.000.00 %0135-
9.502.253.803.013.0250.000.00 %0149-
10.002.704.403.713.550.216.00 %141110/03/2025
10.504.305.004.004.650.000.00 %0204-

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
HMRHeidmar Maritime Holdings Corporation
US$ 2.5599
(69.53%)
37.57M
RDFNRedfin Corporation
US$ 9.76
(67.70%)
92.49M
CKPTCheckpoint Therapeutics Inc
US$ 3.9895
(61.52%)
60.89M
STSSSharps Technology Inc
US$ 0.4399
(48.26%)
591.34M
PTGXProtagonist Therapeutics Inc
US$ 55.91
(45.79%)
5.09M
APEDSTKd 100 percent MSTR and 100 percent COIN ETF
US$ 11.591
(-35.98%)
2.58k
SXTCChina SXT Pharmaceuticals Inc
US$ 2.78
(-35.54%)
162.75k
PCLAPicoCELA Inc
US$ 0.8499
(-35.12%)
866.6k
CONLGraniteShares ETF Trust GraniteShares
US$ 15.685
(-34.86%)
8.63M
MSTXTidal Trust II Defiance Daily Target 2x Long MSTR ETF
US$ 19.22
(-32.95%)
24.05M
STSSSharps Technology Inc
US$ 0.4399
(48.26%)
591.61M
NVDANVIDIA Corporation
US$ 106.98
(-5.07%)
364.12M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.3701
(-30.86%)
258.67M
TSLATesla Inc
US$ 222.15
(-15.43%)
188.57M
TQQQProShares UltraPro QQQ
US$ 59.81
(-11.27%)
155.18M

RXRX Discussion

게시물 보기
Monksdream Monksdream 3 일 전
You have a point

👍️0
bwrbad bwrbad 7 일 전
Cross road,
👍️0
bwrbad bwrbad 2 주 전
can RXRX - star get realignment with ,,,, - asking NVDA's AI brain & Cathy's unknown brain
👍️0
3antar 3antar 2 주 전
Noted. You are so kind
👍️0
peza77 peza77 2 주 전
Hopelessly overvalued, overhyped AI stuff.
ZERO approved products
If this drops to $3, it could still be over-valued
👍️0
bwrbad bwrbad 2 주 전
dark green like black
👍️0
bwrbad bwrbad 3 주 전
Big volume -- could be green EOD
👍️0
bwrbad bwrbad 3 주 전
once cross 36 - it is open sky.
everyday dips are the advantage point
buying the $200 -$300 /sh stock of 2025 at $11 -$36
👍️0
bwrbad bwrbad 3 주 전
could move $3 -$5 today
👍️0
bwrbad bwrbad 3 주 전
You have to have skin in the game!

Reflecting back on #JPM2024 last week and this shot has to be a personal highlight. I was comparing company tattoos with NVIDIA founder & CEO Jensen Huang when @RecursionPharma Board Chair @RMartinChavez dropped his full sleeve Turing machine!… pic.twitter.com/yDPuFVmQ7u— Chris Gibson (@RecursionChris) January 16, 2024
👍️0
TucsonPhil TucsonPhil 3 주 전
I'd wager that undisclosed information is at play, but that wouldn't be legal, so couldn't possibly be the case.
👍️0
3antar 3antar 3 주 전
So why do you think it keeps going higher! 
👍️0
bwrbad bwrbad 3 주 전
blindfold buy at 20 - 30 then the jump 100 - 200
👍️0
bwrbad bwrbad 4 주 전
RXRX
👍️0
TucsonPhil TucsonPhil 4 주 전
They announce a mixed shelf (dilution), and the price spikes?
👍️0
bwrbad bwrbad 4 주 전
RXRX just started little little sprinting step before planting the pole and jump over that record high pole vault bar
👍 1
bwrbad bwrbad 4 주 전
invest - - soon --- before out of reach.
👍️0
bwrbad bwrbad 4 주 전
this is a stock will gain 200-300% in a single day-- but today - no - it will go back to +3c or -3c in 1h
👍️0
TucsonPhil TucsonPhil 1 월 전
This level of result, will make this company fly:

https://www.globenewswire.com/news-release/2025/02/05/3021646/0/en/Recursion-Presents-Phase-2-Data-for-REC-994-in-CCM-in-Late-Breaking-Oral-Presentation-at-the-International-Stroke-Conference.html
👍️ 1
bwrbad bwrbad 1 월 전
generative AI in making medical miracle
👍️0
bwrbad bwrbad 1 월 전
REC-994 MRI-based brainstem lesion volume reduction : place a $M maker brick now
👍️0
bwrbad bwrbad 1 월 전
70 institution 30 public--that's how RXRX drug working now
👍️0
bwrbad bwrbad 1 월 전
YouTube influencer position - write or call cGibson@recursion.com
👍️0
TucsonPhil TucsonPhil 1 월 전
Exactly, when we see the lending fees start to rise, then I will buy more. Brokers always make money, even when investors lose.
👍️0
bwrbad bwrbad 1 월 전
they all do etard fidal TDA, but that gives the opportunity to buy low. This RxRx defines the future of MED world in AI stage- just buying little little within affordability. definitively it will grow like MSTF GOOG AAPL NVDA AMZN.., All drug lords pfizer, j&j eli, merck roche AZ BMS are lining up behind, just give few months to a year for first $100
👍️0
TucsonPhil TucsonPhil 1 월 전
Fidelity is loaning shares to shorts.
👍️0
bwrbad bwrbad 1 월 전
next piece of clinical update will take it above 20 and after that it is in different league.
👍️0
bwrbad bwrbad 1 월 전
Sure looks like early days of ISRG ILMN,
👍️0
TucsonPhil TucsonPhil 2 월 전
Nvidia invested $50M in this company. ARK is a holder. This will be huge, once their first find gets FDA approval, and proof of concept is secured.
👍️ 1
bwrbad bwrbad 2 월 전
interesting no posters in this
future $200 - $300 stock, and that future not far - see the quality of clinical data, target diseases, and the time it took to reach there - not standard 20 ys but 3y to ph3 and a large advancing failure resistant AI powered pipeline
👍️0
bwrbad bwrbad 2 월 전
change of heart -going up.
👍️0
bwrbad bwrbad 2 월 전
rxrx WORLD
👍️0
bwrbad bwrbad 2 월 전
promised to accumulate 10k shares before Q end and hold for years. predict this issue never go BK, do RS, and one day go beyond 200+ like established big cap security issues.
👍️0
bwrbad bwrbad 2 월 전
bandwagon
👍️0
bwrbad bwrbad 2 월 전
believe in miracle ----- come to RXRX------
👍️0
TucsonPhil TucsonPhil 2 월 전
Looks like Lilly is late to the party.

https://www.statnews.com/2025/01/10/eli-lilly-andreessen-horowitz-500-million-venture-fund-ai-focus/
👍️0
bwrbad bwrbad 2 월 전
cursion-re-cursion in flame after FDA REC 3565 blessings
👍️0
bwrbad bwrbad 2 월 전
Gibson🤢🥵🥶😷Gibson
👍️0
bwrbad bwrbad 2 월 전
baby nvda
👍 1
bwrbad bwrbad 2 월 전
balding haircut at RXRX
👍️0
Monksdream Monksdream 3 월 전
RXRX, under $7
👍️0
bwrbad bwrbad 3 월 전
out for now, let CEO work his magic if he has one under his sleeve
👍️0
bwrbad bwrbad 3 월 전
is something wrong with RxRx, it looked promising based on what said to public. but something not right. ground shaken up. - like trouble.
what wrong with the CEO. if this continues that is bad sign for future of the company and the CEO.
👍️0
bwrbad bwrbad 3 월 전
RXRX
👍️0
bwrbad bwrbad 3 월 전
RxRx partnership: GOOG NVDA MSFT Roche/Genentech Bayer Bristol Myers Squibb Sanofi Merck ......
👍 1
bwrbad bwrbad 3 월 전
RxRx M&A: Valence –Cyclica - Exscientia
Valence – a leader in generative AI and deep learning models
Cyclica - a deep learning engine that predicts the polypharmacology of small molecules in drug discovery.
Exscientia - AI-driven precision medicine
RXRX - Regenerative AI - TechBio powerhouse
undergoing post merger reorganization, some job cuts
enough cash to fund through 2027
Ark Q3 2024 Stake: $215.9 million
Hedge Fund Investors Q3 2024:: 16
more than ten drugs in trials.
👍️0
bwrbad bwrbad 3 월 전
market up big and RxRx ignored,
if quantum computing which is 7-10 years away getting attention now, then this should be in the rocket heading for stratosphere.
👍️0
TucsonPhil TucsonPhil 3 월 전
RXRX seeing some promising results in early trials. Proof of concept will solidify belief in the platform.

If cost of trials can be reduced, by less attrition of candidates, then they should see more licensing agreements, and funding, from pharma companies IMO.
👍️ 1
bwrbad bwrbad 3 월 전
Revenue (ttm) 65.18M; Quarterly Revenue Growth (yoy) 147.60%
Total Cash (mrq) 427.65M; Total Debt (mrq) 90.62M
Shares Outstanding 6 388.94M; Float 8 252.42M
clinical trial : REC-994 in Phase 2, REC-2282 in Phase 2/3; few other in phase 1 and 2, all in less than 2 year not 15-18 years (conventional).

% Held by Institutions 1 69.40% Shares Short (Nov 15, 2024) 4 64.57M 25%
👍️ 1
JJ8 JJ8 3 월 전
Rxrx share price Long Tail Up since 06 Dec 2024.
👍️0

최근 히스토리

Delayed Upgrade Clock